Development of nonhuman adenoviruses as vaccine vectors
Identifieur interne : 001764 ( Main/Curation ); précédent : 001763; suivant : 001765Development of nonhuman adenoviruses as vaccine vectors
Auteurs : Dinesh S. Bangari ; Suresh K. MittalSource :
- Vaccine [ 0264-410X ] ; 2005.
Abstract
Human adenoviral (HAd) vectors have demonstrated great potential as vaccine vectors. Preclinical and clinical studies have demonstrated the feasibility of vector design, robust antigen expression and protective immunity using this system. However, clinical use of adenoviral vectors for vaccine purposes is anticipated to be limited by vector immunity that is either preexisting or develops rapidly following the first inoculation with adenoviral vectors. Vector immunity inactivates the vector particles and rapidly removes the transduced cells, thereby limiting the duration of transgene expression. Due to strong vector immunity, subsequent use of the same vector is usually less efficient. In order to circumvent this limitation, nonhuman adenoviral vectors have been proposed as alternative vectors. In addition to eluding HAd immunity, these vectors possess most of the attractive features of HAd vectors. Several replication-competent or replication-defective nonhuman adenoviral vectors have been developed and investigated for their potential as vaccine delivery vectors. Here, we review recent advances in the design and characterization of various nonhuman adenoviral vectors, and discuss their potential applications for human and animal vaccination.
Url:
DOI: 10.1016/j.vaccine.2005.08.101
PubMed: 16297508
PubMed Central: 1462960
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000779
- to stream Pmc, to step Curation: Pour aller vers cette notice dans l'étape Curation :000779
- to stream Pmc, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000990
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :000078
- to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :000078
- to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000078
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :001773
Links to Exploration step
PMC:1462960Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Development of nonhuman adenoviruses as vaccine vectors</title>
<author><name sortKey="Bangari, Dinesh S" sort="Bangari, Dinesh S" uniqKey="Bangari D" first="Dinesh S." last="Bangari">Dinesh S. Bangari</name>
</author>
<author><name sortKey="Mittal, Suresh K" sort="Mittal, Suresh K" uniqKey="Mittal S" first="Suresh K." last="Mittal">Suresh K. Mittal</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">16297508</idno>
<idno type="pmc">1462960</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1462960</idno>
<idno type="RBID">PMC:1462960</idno>
<idno type="doi">10.1016/j.vaccine.2005.08.101</idno>
<date when="2005">2005</date>
<idno type="wicri:Area/Pmc/Corpus">000779</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000779</idno>
<idno type="wicri:Area/Pmc/Curation">000779</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000779</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000990</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000990</idno>
<idno type="wicri:Area/Ncbi/Merge">000078</idno>
<idno type="wicri:Area/Ncbi/Curation">000078</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000078</idno>
<idno type="wicri:doubleKey">0264-410X:2005:Bangari D:development:of:nonhuman</idno>
<idno type="wicri:Area/Main/Merge">001773</idno>
<idno type="wicri:Area/Main/Curation">001764</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Development of nonhuman adenoviruses as vaccine vectors</title>
<author><name sortKey="Bangari, Dinesh S" sort="Bangari, Dinesh S" uniqKey="Bangari D" first="Dinesh S." last="Bangari">Dinesh S. Bangari</name>
</author>
<author><name sortKey="Mittal, Suresh K" sort="Mittal, Suresh K" uniqKey="Mittal S" first="Suresh K." last="Mittal">Suresh K. Mittal</name>
</author>
</analytic>
<series><title level="j">Vaccine</title>
<idno type="ISSN">0264-410X</idno>
<imprint><date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p id="P1">Human adenoviral (HAd) vectors have demonstrated great potential as vaccine vectors. Preclinical and clinical studies have demonstrated the feasibility of vector design, robust antigen expression and protective immunity using this system. However, clinical use of adenoviral vectors for vaccine purposes is anticipated to be limited by vector immunity that is either preexisting or develops rapidly following the first inoculation with adenoviral vectors. Vector immunity inactivates the vector particles and rapidly removes the transduced cells, thereby limiting the duration of transgene expression. Due to strong vector immunity, subsequent use of the same vector is usually less efficient. In order to circumvent this limitation, nonhuman adenoviral vectors have been proposed as alternative vectors. In addition to eluding HAd immunity, these vectors possess most of the attractive features of HAd vectors. Several replication-competent or replication-defective nonhuman adenoviral vectors have been developed and investigated for their potential as vaccine delivery vectors. Here, we review recent advances in the design and characterization of various nonhuman adenoviral vectors, and discuss their potential applications for human and animal vaccination.</p>
</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001764 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 001764 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= CovidV2 |flux= Main |étape= Curation |type= RBID |clé= PMC:1462960 |texte= Development of nonhuman adenoviruses as vaccine vectors }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/RBID.i -Sk "pubmed:16297508" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd \ | NlmPubMed2Wicri -a CovidV2
This area was generated with Dilib version V0.6.33. |